menu search

Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023

Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
— China commercial launch in multiple provinces and municipalities expected to begin in Q1 2023, and Clover anticipates a significant and sustained long-term annual booster market for its premium, broadly protective protein-based COVID-19 vaccines in China — — SCB-2019 (CpG 1018/Alum) anticipated to receive emergency use authorization (EUA) in at least one additional country and […] The post Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023 appeared f... Read More
Posted: Jan 16 2023, 00:00
Author Name: forextv
Views: 102520

Search within

Pages Search Results: